Get started
ASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHSASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHSASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHS

ASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

0A4J chart


Full chart

Key facts today

UBS analyst Matthew Weston upgraded the rating for AstraZeneca PLC from Sell to Neutral, with shares closing at $63.80 on Tuesday.
Aradhana Sarin, CFO of AstraZeneca, presented at CECP's CEO Investor Forum, discussing the company's Integrated Long-Term Plans for AI.
Analyze the impactAnalyze the impact

0A4J upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪195.52 B‬ USD
Dividend yield (indicated)
2.30%
Price to earnings Ratio (TTM)
30.5
Basic EPS (TTM)
2.0 USD
Net income (FY)
‪5.96 B‬ USD
Revenue (FY)
‪45.81 B‬ USD
Shares float
‪3.10 B‬
Beta (1Y)
0.04

About ASTRAZENECA PLC ORD USD0.25


Sector
Health Technology
CEO
Pascal Soriot
Headquarters
Cambridge
Website
astrazeneca.co.uk
Founded
1992
FIGI
BBG00X9DN9C1
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0A4J news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

0A4J highest yielding bonds


US46353AX6
ASTRAZENECA 20/50
Yield to maturity
6.91%
Maturity date
Aug 6, 2050
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
6.33%
Maturity date
May 28, 2051
US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.74%
Maturity date
Nov 16, 2045
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.73%
Maturity date
Aug 17, 2048
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.54%
Maturity date
Sep 18, 2042
US46353AW8
ASTRAZENECA 20/30
Yield to maturity
5.20%
Maturity date
Aug 6, 2030
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
5.17%
Maturity date
May 28, 2031
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
5.06%
Maturity date
Sep 15, 2037
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
5.05%
Maturity date
Feb 26, 2034
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.93%
Maturity date
Mar 3, 2033
A
AZN5193317
AstraZeneca Finance LLC 1.75% 28-MAY-2028
Yield to maturity
4.85%
Maturity date
May 28, 2028

Explore more bonds 

Sparks


Curated watchlists where 0A4J is featured.

See all sparks